Geert Cauwenbergh
2014
In 2014, Geert Cauwenbergh earned a total compensation of $801.7K as President, Chief Executive Officer and acting Chief Financial Officer at RXi Pharmaceuticals, a 27% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $114,000 |
|---|---|
| Option Awards | $305,900 |
| Salary | $381,274 |
| Other | $552 |
| Total | $801,726 |
Cauwenbergh received $381.3K in salary, accounting for 48% of the total pay in 2014.
Cauwenbergh also received $114K in non-equity incentive plan, $305.9K in option awards and $552 in other compensation.
Rankings
In 2014, Geert Cauwenbergh's compensation ranked 8,517th out of 13,032 executives tracked by ExecPay. In other words, Cauwenbergh earned more than 34.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,517 out of 13,032 | 35th |
Division Manufacturing | 3,165 out of 4,966 | 36th |
Major group Chemicals And Allied Products | 1,069 out of 1,686 | 37th |
Industry group Drugs | 846 out of 1,365 | 38th |
Industry Pharmaceutical Preparations | 656 out of 1,043 | 37th |
Source: SEC filing on November 4, 2016.
Cauwenbergh's colleagues
We found one more compensation record of an executive who worked with Geert Cauwenbergh at RXi Pharmaceuticals in 2014.
2014
Pamela Pavco
RXi Pharmaceuticals